Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...
Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...